BackMorphosys AG Overview

Morphosys AG Current Cash

Morphosys AG's current cash is $130M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$131.26M
55.01% YoYΔ $-160.49M vs prior year quarter

Peer trimmed avg / median

Loading

Morphosys AG Current Cash History

Loading

Morphosys AG vs. peers: Current Cash Comparison

Loading

Morphosys AG Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Morphosys AG (MOR) FAQ

The latest current cash for MOR is $130M as of March 2024. That compares with $290M in the prior-year period — down 55.0% year over year. Investors often review this figure alongside Morphosys AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, MOR's current cash moved from $290M to $130M — a 55.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Morphosys AG's operating scale or balance-sheet position.

A current cash figure of $130M for MOR is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MOR's current cash ($130M), review year-over-year change from $290M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Morphosys AG's current cash against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.